Apimeds Pharmaceuticals US, Inc. (APUS) Shareholders’ equity
Apimeds Pharmaceuticals US, Inc. (APUS) shareholders’ equity at each fiscal year-end, per SEC filings.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to APUSSource: SEC XBRL filings · For reference only · Not investment advice